Kenvue Inc. logo
Kenvue Inc. (KVUE)
Compare

Kenvue Inc. (KVUE) Average EV/EBIT Ratio

EV/EBIT Ratio

The current ev/ebit ratio for Kenvue Inc. (KVUE) is 14.32x as of Wednesday, June 24, 2026, shown against its trailing averages.

KVUE EV/EBIT Ratio

KVUE Average EV/EBIT Ratio Chart

KVUE EV/EBIT Ratio Averages

EV/EBIT RATIO CURRENT

14.32x

EV/EBIT RATIO TTM

17.76x

EV/EBIT RATIO 3Y

20.64x

EV/EBIT RATIO 5Y

20.50x

EV/EBIT RATIO 10Y

20.50x

EV/EBIT RATIO 15Y

20.50x

EV/EBIT RATIO 20Y

20.50x

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ
22,000 employees
Consumer Defensive / Household & Personal Products
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Kirk L. Perry